Page last updated: 2024-09-03

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and stilbenes

gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with stilbenes in 1 studies

Compound Research Comparison

Studies
(gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate)
Trials
(gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate)
Recent Studies (post-2010)
(gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate)
Studies
(stilbenes)
Trials
(stilbenes)
Recent Studies (post-2010) (stilbenes)
6383124313,9352457,836

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bouzin, C; Cron, GO; Feron, O; Fruytier, AC; Gallez, B; Jordan, B; Karroum, O; Magat, J; Neveu, MA1

Other Studies

1 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and stilbenes

ArticleYear
Dynamic contrast-enhanced MRI in mouse tumors at 11.7 T: comparison of three contrast agents with different molecular weights to assess the early effects of combretastatin A4.
    NMR in biomedicine, 2014, Volume: 27, Issue:11

    Topics: Animals; Animals, Outbred Strains; Antineoplastic Agents, Phytogenic; Capillary Permeability; Contrast Media; Drug Monitoring; Endothelial Cells; Feasibility Studies; Hemodynamics; Heterocyclic Compounds; Hindlimb; Liver Neoplasms, Experimental; Magnetic Resonance Imaging; Male; Mice; Molecular Weight; Neoplasm Transplantation; Organometallic Compounds; Stilbenes; Transplantation, Heterotopic; Tubulin Modulators; Tumor Burden

2014